0.013532 0.000000 0.000000 0.000000 0.013532 0.000000 0.000000 0.000000 0.023310 0.00000 0.00000 0.00000 Naismith, J.H. Giraud, M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.00 90.00 90.00 73.900 73.900 42.900 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking DK Acta Crystallogr.,Sect.D ABCRE6 0766 0907-4449 54 891 898 10.1107/S0907444998002480 9757105 Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin. 1998 To be Published 0353 The Structure of Ubch9: A Sumo Conjugating Enzyme 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 298 1 MIRRORS IMAGE PLATE 1997-08 BRUKER NONIUS NI FILTER M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE ENRAF-NONIUS FR591 18174.945 UBC9 6.3.2.19 1 man polymer UBCH9, UBE9, UBCI no no GSMSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFE PPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS GSMSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFE PPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample GST-FUSION 9606 Homo sapiens 562 Escherichia coli 1 3.22 61.80 7. pH 7. repository Initial release Version format compliance Version format compliance 1 0 1998-05-27 1 1 2008-03-24 1 2 2011-07-13 Y BNL 1998-01-23 REL REL n 1 -1 A n 2 0 A MET 1 n 3 MET 1 A SER 2 n 4 SER 2 A GLY 3 n 5 GLY 3 A ILE 4 n 6 ILE 4 A ALA 5 n 7 ALA 5 A LEU 6 n 8 LEU 6 A SER 7 n 9 SER 7 A ARG 8 n 10 ARG 8 A LEU 9 n 11 LEU 9 A ALA 10 n 12 ALA 10 A GLN 11 n 13 GLN 11 A GLU 12 n 14 GLU 12 A ARG 13 n 15 ARG 13 A LYS 14 n 16 LYS 14 A ALA 15 n 17 ALA 15 A TRP 16 n 18 TRP 16 A ARG 17 n 19 ARG 17 A LYS 18 n 20 LYS 18 A ASP 19 n 21 ASP 19 A HIS 20 n 22 HIS 20 A PRO 21 n 23 PRO 21 A PHE 22 n 24 PHE 22 A GLY 23 n 25 GLY 23 A PHE 24 n 26 PHE 24 A VAL 25 n 27 VAL 25 A ALA 26 n 28 ALA 26 A VAL 27 n 29 VAL 27 A PRO 28 n 30 PRO 28 A THR 29 n 31 THR 29 A LYS 30 n 32 LYS 30 A ASN 31 n 33 ASN 31 A PRO 32 n 34 PRO 32 A ASP 33 n 35 ASP 33 A GLY 34 n 36 GLY 34 A THR 35 n 37 THR 35 A MET 36 n 38 MET 36 A ASN 37 n 39 ASN 37 A LEU 38 n 40 LEU 38 A MET 39 n 41 MET 39 A ASN 40 n 42 ASN 40 A TRP 41 n 43 TRP 41 A GLU 42 n 44 GLU 42 A CYS 43 n 45 CYS 43 A ALA 44 n 46 ALA 44 A ILE 45 n 47 ILE 45 A PRO 46 n 48 PRO 46 A GLY 47 n 49 GLY 47 A LYS 48 n 50 LYS 48 A LYS 49 n 51 LYS 49 A GLY 50 n 52 GLY 50 A THR 51 n 53 THR 51 A PRO 52 n 54 PRO 52 A TRP 53 n 55 TRP 53 A GLU 54 n 56 GLU 54 A GLY 55 n 57 GLY 55 A GLY 56 n 58 GLY 56 A LEU 57 n 59 LEU 57 A PHE 58 n 60 PHE 58 A LYS 59 n 61 LYS 59 A LEU 60 n 62 LEU 60 A ARG 61 n 63 ARG 61 A MET 62 n 64 MET 62 A LEU 63 n 65 LEU 63 A PHE 64 n 66 PHE 64 A LYS 65 n 67 LYS 65 A ASP 66 n 68 ASP 66 A ASP 67 n 69 ASP 67 A TYR 68 n 70 TYR 68 A PRO 69 n 71 PRO 69 A SER 70 n 72 SER 70 A SER 71 n 73 SER 71 A PRO 72 n 74 PRO 72 A PRO 73 n 75 PRO 73 A LYS 74 n 76 LYS 74 A CYS 75 n 77 CYS 75 A LYS 76 n 78 LYS 76 A PHE 77 n 79 PHE 77 A GLU 78 n 80 GLU 78 A PRO 79 n 81 PRO 79 A PRO 80 n 82 PRO 80 A LEU 81 n 83 LEU 81 A PHE 82 n 84 PHE 82 A HIS 83 n 85 HIS 83 A PRO 84 n 86 PRO 84 A ASN 85 n 87 ASN 85 A VAL 86 n 88 VAL 86 A TYR 87 n 89 TYR 87 A PRO 88 n 90 PRO 88 A SER 89 n 91 SER 89 A GLY 90 n 92 GLY 90 A THR 91 n 93 THR 91 A VAL 92 n 94 VAL 92 A CYS 93 n 95 CYS 93 A LEU 94 n 96 LEU 94 A SER 95 n 97 SER 95 A ILE 96 n 98 ILE 96 A LEU 97 n 99 LEU 97 A GLU 98 n 100 GLU 98 A GLU 99 n 101 GLU 99 A ASP 100 n 102 ASP 100 A LYS 101 n 103 LYS 101 A ASP 102 n 104 ASP 102 A TRP 103 n 105 TRP 103 A ARG 104 n 106 ARG 104 A PRO 105 n 107 PRO 105 A ALA 106 n 108 ALA 106 A ILE 107 n 109 ILE 107 A THR 108 n 110 THR 108 A ILE 109 n 111 ILE 109 A LYS 110 n 112 LYS 110 A GLN 111 n 113 GLN 111 A ILE 112 n 114 ILE 112 A LEU 113 n 115 LEU 113 A LEU 114 n 116 LEU 114 A GLY 115 n 117 GLY 115 A ILE 116 n 118 ILE 116 A GLN 117 n 119 GLN 117 A GLU 118 n 120 GLU 118 A LEU 119 n 121 LEU 119 A LEU 120 n 122 LEU 120 A ASN 121 n 123 ASN 121 A GLU 122 n 124 GLU 122 A PRO 123 n 125 PRO 123 A ASN 124 n 126 ASN 124 A ILE 125 n 127 ILE 125 A GLN 126 n 128 GLN 126 A ASP 127 n 129 ASP 127 A PRO 128 n 130 PRO 128 A ALA 129 n 131 ALA 129 A GLN 130 n 132 GLN 130 A ALA 131 n 133 ALA 131 A GLU 132 n 134 GLU 132 A ALA 133 n 135 ALA 133 A TYR 134 n 136 TYR 134 A THR 135 n 137 THR 135 A ILE 136 n 138 ILE 136 A TYR 137 n 139 TYR 137 A CYS 138 n 140 CYS 138 A GLN 139 n 141 GLN 139 A ASN 140 n 142 ASN 140 A ARG 141 n 143 ARG 141 A VAL 142 n 144 VAL 142 A GLU 143 n 145 GLU 143 A TYR 144 n 146 TYR 144 A GLU 145 n 147 GLU 145 A LYS 146 n 148 LYS 146 A ARG 147 n 149 ARG 147 A VAL 148 n 150 VAL 148 A ARG 149 n 151 ARG 149 A ALA 150 n 152 ALA 150 A GLN 151 n 153 GLN 151 A ALA 152 n 154 ALA 152 A LYS 153 n 155 LYS 153 A LYS 154 n 156 LYS 154 A PHE 155 n 157 PHE 155 A ALA 156 n 158 ALA 156 A PRO 157 n 159 PRO 157 A SER 158 n 160 SER 158 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 25 A O VAL 27 A N ALA 44 A N ALA 46 A O TRP 41 A O TRP 43 A N MET 62 A N MET 64 A O ARG 61 A O ARG 63 A N LYS 76 A N LYS 78 1 A GLY -1 A GLY 1 1 Y 1 A SER 0 A SER 2 1 Y 1 A MET 1 A MET 3 0 Y 1 A PRO 32 A PRO 34 0 Y 1 A ASP 33 A ASP 35 0 Y 1 A GLY 34 A GLY 36 0 Y 1 A THR 35 A THR 37 0 Y 1 9.78 1.50 119.30 129.08 A A A C N CA ASP PRO PRO 127 128 128 Y 1 A SER 2 -49.11 178.29 1 A PRO 32 -52.93 178.18 1 A ASP 33 28.53 82.74 1 A THR 35 -55.14 -152.16 1 A MET 36 177.27 150.85 1 A TYR 68 -24.72 130.72 1 A LYS 101 -106.60 -116.19 1 A ASN 140 -178.53 61.65 PROTEIN_REP.PARAM PROTEIN.TOP PROTEIN.LINK 42.5 7.6 0. 0. 7.6 0. -15.2 ATOMS WITH ZERO OCCUPANCY AR E MODELLED AND WERE NOT LOCATED BY EXPERIMENTAL DENSITY. DATA CUTOFF HIGH (ABS(F)) : 9999999999 DATA CUTOFF LOW (ABS(F)) : 0 0.2600000 0.01 0.2100000 0.2100000 2.8 560 5605 10. 96. RANDOM 9999999999 1 RESTRAINED THROUGHOUT 0. MOLECULAR REPLACEMENT PDB ENTRY 1AAK DENSITY MODIFICATION 34.51 0.325 0.47 0.37 5.0 0.64 0.54 2.8 0 1268 0 0 1268 0.011 1.87 22.06 1.00 2.67 1.5 4.09 2.0 4.35 2.0 5.71 2.5 0.4300000 0.07 0.3100000 2.9 42 435 10 10. 81. 43.8 2.8 1A3S 5605 0. 0.1000000 0.1000000 1 7.2 3.1 96. 0.1900000 2.8 2.9 2.4 0.1900000 2.0 81. phasing AMoRE refinement CNS 0.2 data reduction DENZO data scaling SCALEPACK UBC9 HUMAN UBC9 1 N N A ILE 4 A ILE 6 HELX_P A LYS 18 A LYS 20 1 1 15 A SER 95 A SER 97 HELX_P A LEU 97 A LEU 99 5 2 3 A ILE 109 A ILE 111 HELX_P A ASN 121 A ASN 123 1 3 13 A ALA 131 A ALA 133 HELX_P A GLN 139 A GLN 141 1 4 9 A ARG 141 A ARG 143 HELX_P A LYS 154 A LYS 156 1 5 14 SUMO CONJUGATING ENZYME SUMO CONJUGATING ENZYME, UBIQUITIN CONJUGATING ENZYME A TYR 68 A TYR 70 1 A PRO 69 A PRO 71 0.17 A GLU 78 A GLU 80 1 A PRO 79 A PRO 81 -5.27 UBE2I_HUMAN UNP 1 1 P63279 MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPP LFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS 1 158 1A3S 1 158 P63279 A 1 3 160 4 anti-parallel anti-parallel anti-parallel A VAL 25 A VAL 27 A PRO 28 A PRO 30 A ASN 40 A ASN 42 A PRO 46 A PRO 48 A LEU 57 A LEU 59 A LEU 63 A LEU 65 A LYS 74 A LYS 76 A PHE 77 A PHE 79 78 P 43